Amaryllis Nucleics' Seed Round

Amaryllis Nucleics raised a round of funding on March 14, 2015. Investors include IndieBio.

Amaryllis Nucleics is creating technology that reduces the time and cost of RNA sequencing in order to empower cancer diagnostics, pharmaceutical development, and food security innovations.…

Articles about Amaryllis Nucleics' Seed Round: